share_log

Huaxia Eye Hospital GroupLtd (SZSE:301267) Has A Rock Solid Balance Sheet

Huaxia Eye Hospital GroupLtd (SZSE:301267) Has A Rock Solid Balance Sheet

華夏眼科醫院集團有限公司(深圳證券交易所代碼:301267)的資產負債表堅如磐石
Simply Wall St ·  05/27 22:56

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. As with many other companies Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267) makes use of debt. But the real question is whether this debt is making the company risky.

有人認爲波動性而不是債務是投資者思考風險的最佳方式,但是禾倫·巴菲特曾經著名地說過:“波動性並非風險的同義詞。” 當您審查一個公司的風險時,自然會考慮其資產負債表,因爲當業務崩潰時,往往涉及債務。正如許多其他公司一樣,華夏眼科醫院集團股份有限公司(SZSE:301267)利用債務。 但真正的問題是:這筆債務是否使公司具有風險。

When Is Debt A Problem?

什麼時候負債才是一個問題?

Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.

通常情況下,當一家公司不能輕易償還債務時,債務才會成爲真正的問題,無論是通過籌集資本還是藉助自身的現金流。最終,如果公司無法履行償還債務的法律義務,股東可能會一無所有。儘管這並不太常見,但我們經常看到負債的公司因爲貸方強制它們以低於正常價格的價格籌集資本而永久稀釋股東。儘管如此,最常見的情況是,一家公司合理地管理其債務,並獲取自身優勢。考慮企業使用了多少負債時,首先要做的就是將其現金和債務放在一起看。

What Is Huaxia Eye Hospital GroupLtd's Net Debt?

華夏眼科醫院集團有限公司的淨債務是多少?

The chart below, which you can click on for greater detail, shows that Huaxia Eye Hospital GroupLtd had CN¥25.1m in debt in March 2024; about the same as the year before. But it also has CN¥4.10b in cash to offset that, meaning it has CN¥4.07b net cash.

下面的圖表詳細說明了華夏眼科醫院集團股份有限公司截至2024年3月的債務情況;與前一年大致相同。 但它也擁有41億人民幣的現金來抵消這些債務,這意味着它有40.7億人民幣的淨現金。

debt-equity-history-analysis
SZSE:301267 Debt to Equity History May 28th 2024
SZSE:301267資產負債歷史記錄2024年5月28日

How Strong Is Huaxia Eye Hospital GroupLtd's Balance Sheet?

華夏眼科醫院集團股份有限公司的資產負債表有多強?

The latest balance sheet data shows that Huaxia Eye Hospital GroupLtd had liabilities of CN¥974.6m due within a year, and liabilities of CN¥756.2m falling due after that. Offsetting these obligations, it had cash of CN¥4.10b as well as receivables valued at CN¥441.3m due within 12 months. So it can boast CN¥2.81b more liquid assets than total liabilities.

最新的資產負債表數據顯示,華夏眼科醫院集團股份有限公司在一年內有價值974.6萬元的負債,並有756.2萬元的負債到期後。 抵消這些債務,它有41億元的現金以及12個月內到期的應收賬款爲4.413億元。 因此,它擁有比其他公司多281億元的流動資產。負債。

This surplus suggests that Huaxia Eye Hospital GroupLtd has a conservative balance sheet, and could probably eliminate its debt without much difficulty. Simply put, the fact that Huaxia Eye Hospital GroupLtd has more cash than debt is arguably a good indication that it can manage its debt safely.

這種盈餘表明華夏眼科醫院集團股份有限公司擁有保守的資產負債表,並且可能很容易消除其債務。 簡而言之,華夏眼科醫院集團股份有限公司擁有更多的現金而不是債務,這可能是它可以安全地管理其債務的好跡象。

And we also note warmly that Huaxia Eye Hospital GroupLtd grew its EBIT by 14% last year, making its debt load easier to handle. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately the future profitability of the business will decide if Huaxia Eye Hospital GroupLtd can strengthen its balance sheet over time. So if you're focused on the future you can check out this free report showing analyst profit forecasts.

我們還注意到,華夏眼科醫院集團股份有限公司去年的息稅前利潤增長了14%,這使其更容易處理債務負擔。 在分析債務水平時,資產負債表是明顯的起點。 但最終業務的未來盈利能力將決定華夏眼科醫院集團股份有限公司是否能夠隨着時間的推移加強其資產負債表。 因此,如果您關注未來,您可以查看此免費報告,其中顯示了分析師盈利預測。

Finally, a company can only pay off debt with cold hard cash, not accounting profits. While Huaxia Eye Hospital GroupLtd has net cash on its balance sheet, it's still worth taking a look at its ability to convert earnings before interest and tax (EBIT) to free cash flow, to help us understand how quickly it is building (or eroding) that cash balance. Over the most recent three years, Huaxia Eye Hospital GroupLtd recorded free cash flow worth 73% of its EBIT, which is around normal, given free cash flow excludes interest and tax. This free cash flow puts the company in a good position to pay down debt, when appropriate.

最後,公司只能用冰冷的硬現金而不是會計利潤償還債務。 雖然華夏眼科醫院集團股份有限公司在其資產負債表上擁有淨現金,但仍值得看一下將息稅前利潤(EBIT)轉化爲自由現金流的能力,這可以幫助我們理解它構建(或侵蝕)現金平衡的速度。 在最近的三年中,華夏眼科醫院集團股份有限公司記錄的自由現金流價值相當於其EBIT的73%,這是很正常的,因爲自由現金流不包括利息和稅款。該自由現金流使公司有能力適時償還債務。

Summing Up

總之

While we empathize with investors who find debt concerning, you should keep in mind that Huaxia Eye Hospital GroupLtd has net cash of CN¥4.07b, as well as more liquid assets than liabilities. And it impressed us with free cash flow of CN¥405m, being 73% of its EBIT. So is Huaxia Eye Hospital GroupLtd's debt a risk? It doesn't seem so to us. Over time, share prices tend to follow earnings per share, so if you're interested in Huaxia Eye Hospital GroupLtd, you may well want to click here to check an interactive graph of its earnings per share history.

雖然我們同情認爲債務令人擔憂的投資者,但您應該記住,華夏眼科醫院集團股份有限公司除了擁有淨現金41.07億人民幣外,還擁有比負債多的流動資產。 而且其4.05億元人民幣的自由現金流令我們印象深刻,相當於其EBIT的73%。 因此,華夏眼科醫院集團股份有限公司的債務是否具有風險? 對我們來說似乎並非如此。 隨着時間的推移,股價往往會跟隨每股收益,因此如果您對華夏眼科醫院集團股份有限公司感興趣,您可能需要單擊此處,查看其每股收益歷史的交互式圖表。

At the end of the day, it's often better to focus on companies that are free from net debt. You can access our special list of such companies (all with a track record of profit growth). It's free.

總的來說,專注於沒有淨債務的公司往往更好。您可以訪問我們的特別列表,其中包含這些公司(所有這些公司都有盈利增長的記錄)。這是免費的。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或者,發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論